AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05922189 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SBS Decompression Technique
Description: The investigator who applied the technique stood on the right side, laterally to the headboard of the table, with feet flat on the floor, at an appropriate level in relation to the volunteer's headboard, and with a glove on his right hand. Then, he contacted the volunteer's sphenoid wings with his left hand and asked the volunteer to open her mouth, contacting the upper dental arch with the second and third fingers of his right hand. Subsequently, the investigator brought both hands together, followed by an inspiration towards the floor and then a translation towards the ceiling until he felt the structures relax, with a maximum duration of 5 minutes. A second Investigator was sitting on a chair, placed on the opposite side of the head of the table with a stopwatch in his dominant hand, in order to time the application time of each technique.
Study NCT05922189 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Technique
Description: The investigator was standing, on the right side, laterally to the headboard of the table with feet flat on the floor, at an appropriate level in relation to the headboard of the volunteer's and with a glove on his right hand. Then, he contacted the participant's sphenoid wings with his left hand and asked her to open her mouth. With the second and third fingers of the right hand, he made contact with the upper dental arch. These contacts were maintained for 2 minutes, without moving. A second investigator sat on a chair, placed on the opposite side of the table with the stopwatch in his dominant hand, in order to time the application time of each technique.
Study NCT06219096 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: NIF image-guided laparoscopic anatomical liver resection with the novel ICG@HSA administration
Description: After ligation of the target hepatic segmental portal vein, the novel ICG regimen (0.5 mg ICG powder and 500 mg human serum albumin added to 20 ml saline, shaken and allowed to stand for more than 5 minutes, ICG: 0.025 mg/ml, human serum albumin: 25 mg/ml) was intravenously infused continuously at a rate of 1 ml/min until significant fluorescence imaging appeared in the demarcated area, upon which the infusion was terminated.
Study NCT06219096 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: NIF image-guided laparoscopic anatomical liver resection with the guideline-recommended ICG administration
Description: After ligation of the target hepatic segmental portal vein, 2.5 mg of ICG (2.5 mg/ml) was intravenously injected.
Study NCT06461832 — intervention group
Intervention type: PROCEDURE
Intervention: Group 1
Description: In patients undergoing a hysterectomy, an epidural catheter is placed via the L3-4 or L4-5 spinal space, followed by the application of a standardized general anesthesia protocol.
Study NCT06461832 — intervention group
Intervention type: PROCEDURE
Intervention: Group 2
Description: In patients undergoing hysterectomy, 15-20 mg of heavy bupivacaine is injected into the intrathecal area via the L3-4 or L4-5 spinal space, using a spinal needle. Following the removal of the spinal needle, an epidural catheter is then placed through the same opening.
Study NCT04818970 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Narrow Band ultraviolet B-Band Light
Description: Daily doses of NB-UVB for 8 consecutive days.
Study NCT04818970 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: non Narrow Band ultraviolet B-Band Light
Description: Daily doses of non-NB-UVB for 8 consecutive days.
Study NCT05083533 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: tele-rehabilitation exercise
Description: Telerehabilitation allows patients to interact with providers remotely and can be used both to assess patients and to deliver therapy. Treatment program planned to stretch the muscles of individuals with short hamstring muscle group.~Stretching exercises for hamstring muscle group shortening were applied 4 days a week, which lasted for 8 weeks in total. For the first four weeks, 3 different stretching exercises per day were planned and performed as 10 seconds of stretching and 5 repetitions. For the last four weeks, 4 different stretching exercises were planned per day and performed with 20 seconds of stretching and 10 repetitions.
Study NCT05083533 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Home exercise
Description: All participants received home exercise for 8 weeks. The exercise program includes stretching exercises Stretching exercises for hamstring muscle group shortening were applied 4 days a week, which lasted for 8 weeks in total. For the first four weeks, 3 different stretching exercises per day were planned and performed as 10 seconds of stretching and 5 repetitions. For the last four weeks, 4 different stretching exercises were planned per day and performed with 20 seconds of stretching and 10 repetitions.
Study NCT04869540 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: Evidence based care for transition-aged youth (TAY) with ASD.
Study NCT04869540 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual care
Description: Evidence based care for transition-aged youth (TAY) with ASD.
Study NCT04869540 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 'Got Transition' toolkit and resources
Description: Providers will be trained in the 'Got Transition' toolkit (the systems level component of the intervention) and have access to web-based transition resources.
Study NCT04869540 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 'Got Transition' toolkit and resources
Description: Providers will be trained in the 'Got Transition' toolkit (the systems level component of the intervention) and have access to web-based transition resources.
Study NCT04869540 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PSE intervention
Description: A family-based problem solving education (PSE) intervention.
Study NCT04603261 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Contrast concentration in urine
Description: Iodinated contrast content of urine samples, collected post-contrast over a period of 5 days at all times of natural excretion within that period, will be assayed.~Serum creatinine will be measured daily before (day 0) and during 5 days post-contrast, and again at 1 month post-contrast.
Study NCT04800458 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Blood samples
Description: * Thrombopoietin : 7 ml whole blood.~* Anti-platelet antibodies free : 14 ml whole blood.~* Anti-platelet antibodies bound :~If the platelet count is ≥ 50 G / L : 14 ml whole blood for Peripheral blood mononuclear cell (PBMC) and monocytes isolation ; If the platelet count is \< 50 G / L and ≥ 20 G / L : 28 ml whole blood for Peripheral blood mononuclear cell (PBMC) and monocytes isolation ; If the platelet count is \< 20 G / L and ≥ 10 G / L: 42 ml whole blood for Peripheral blood mononuclear cell (PBMC) and monocytes isolation ; If the platelet count is \< 10 G / L : 49 ml whole blood for Peripheral blood mononuclear cell (PBMC) and monocytes isolation.
Study NCT04950465 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sensodyne Sensitivity & Gum
Description: Sensodyne Sensitivity \& Gum toothpaste containing 0.454% SnF2.
Study NCT04950465 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Crest Cavity Protection Fresh Lime
Description: Crest Cavity Protection Fresh Lime is containing 1150 parts per million fluoride as Sodium fluoride.
Study NCT04950465 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Sensodyne Repair and Protect
Description: Sensodyne Repair and Protect dentifrice containing 5.0% weight/weight calcium sodium phosphosilicate.
Study NCT04855643 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: home-based active tDCS
Description: Anode and cathode electrodes will be placed over the left and right dorsolateral prefrontal cortexes, respectively, with the use of the Omni-Lateral-Electrode system. Caregivers will set up and administer tDCS for participants with ADRD at home. tDCS will be applied for 30 min at an intensity of 2mA, with 30 s ramping up and down. All sessions will be remotely supervised by trained research staff.
Study NCT04855643 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: home-based sham tDCS
Description: For sham stimulation, electric current will be applied only in the first 30s tDCS. All sessions will be remotely supervised by trained research staff.
Study NCT06581510 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: esthetic dental crowns
Description: Minimal Preparation of esthetic dental crown
Study NCT06581510 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: control group
Description: Nuu smile ready-made zirconia crown with its well-known reduction
Study NCT06582069 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bleaching
Description: Bleaching
Study NCT05848895 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Osteopathic Manipulative Treatment
Description: Osteopathic Manipulative Treatment is a manual treatment therapy applied by licensed physicians that consists of using ones hands to improve the structure and function of the body. In this situation it will involve gentle and passive modalities that are well-tolerated by infants.
Study NCT05848895 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care Repositioning
Description: Parents will receive standardized handouts/materials instructing on repositioning intended to help improve head shape in infants with plagiocephaly.
Study NCT06369974 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antisense oligonucleotide treatment (ASO)
Description: Drug: nL-TUBB4-001; Personalized antisense oligonucleotide
Study NCT05279287 — intervention group
Intervention type: OTHER
Intervention: Video and kinematic data recording of minimally invasive surgical procedure
Description: Analysis of video and kinematic data through validated methodology in order to analyse technical performance and errors enacted intraoperatively.
Study NCT05749549 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR1733
Description: Subjects will receive oral administration of BR1733.
Study NCT05676307 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Vestibular Rehabilitation
Description: Cawthorne Cooksey Based Vestibular Rehabilitation Exercises (Oculomotor exercise, Vestibulo-ocular Exercise, posture exercise, balance training, etc)
Study NCT05742607 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IPH5201 + durvalumab + standard chemotherapy
Description: Patients will receive Neoadjuvant therapy with IPH5201 and durvalumab in addition to standard chemotherapy.~Following surgery, patients will receive adjuvant treatment with IPH5201 and durvalumab.
Study NCT06096506 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual Culinary Medicine
Description: The virtual curriculum will include five 90-minute sessions (to be held weekly or bi-weekly). Participants will also be expected to shop for groceries ahead of the sessions to participate in the program. A gift card will be provided for groceries ($30 per class = $150 total).Asynchronous virtual educational content (cooking skills videos, animated nutrition education videos, and additional recipes) will be provided to engage and retain participants beyond initial sessions
Study NCT05982847 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood pressure screening
Description: Blood pressure and anthropometric measurements will be performed in children and adolescents between ages 5-18 years to develop South African nomograms that will aid in the development of clinical practice guidelines to optimise hypertension care in South Africa youth.
Study NCT06175481 — intervention group
Intervention type: OTHER
Intervention: Popliteal Vein Compliance
Description: Compliance of the popliteal vein is calculated as the distensibility, with the ratio of functional caliber/native caliber/cuff pressure value ( mmHg-1 ).
Study NCT06473220 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Narrative nursing
Description: Narrative nursing is an intervention mode of psychological nursing.
Study NCT06473220 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Narrative nursing
Description: Narrative nursing is an intervention mode of psychological nursing.
Study NCT04782778 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine 0.25% Injectable Solution
Description: 1 mg/kg Bupivacaine (0.25%)
Study NCT05976919 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Pulmonary function testing
Description: Physiological assessment of pulmonary physiology (large and small airways), exercise capacity, physical activity and body composition.
Study NCT05909371 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercise
Description: Application of two different exercises to liver transplant individuals.
Study NCT05627635 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Balstilimab
Description: Given IV
Study NCT05627635 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Given IV
Study NCT05627635 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo a blood sample collection
Study NCT01010724 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: bIAP
Study NCT05627635 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Botensilimab
Description: Given IV
Study NCT05627635 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo a CT scan
Study NCT05627635 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluorouracil
Description: Given IV
Study NCT05627635 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Leucovorin Calcium
Description: Given IV
Study NCT01010724 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT05547516 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard infusion chemotherapy
Description: standard infusion chemotherapy (including gemcitabine, mitomycin, epirubicin, etc.), dissolved in 50mL normal saline or glucose, intravesical infusion chemotherapy, retained for 60min. Perfusion can be performed within 24 hours after surgery, and then once a week for a total of 8 times, and then once a month until 12 months after surgery
Study NCT05547516 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: BL - 5 ala PDT
Description: BL - 5 ala PDT - plan: 5ALA 1.5g (Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd), dissolved in 50mL normal saline, was infused into the bladder for 2 hours before surgery and before each cystoscopy. Blue laser irradiation was performed under a flexible cystoscope at 30mW/cm2 for 21min. PDT was performed during the operation and at 3, 6, and 9 months after the operation.
Study NCT05627635 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT05627635 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: Given IV
Study NCT05994729 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Invasive Physiological Assessment of Coronary Circulation
Description: After 2 months long rule-in phase required to exclude the unsuitable patients, study population will undergo RDN as indicated to treat resistant or difficult to control hypertension; 12 months after RDN, they will undergo invasive physiological study, comprehensive of Coronary Flow Reserve, Index of Microvascular Resistance, Mean Transit Time. These data will be then compared to the baseline ones obtained during the screening phase.
Study NCT06273176 — intervention group
Intervention type: PROCEDURE
Intervention: Awake mapping under local anesthesia
Description: During an awake craniotomy, the patient is awake and cooperative during the resection of the tumor while the surgeon uses electro(sub)cortical mapping to prevent damage to eloquent areas.
Study NCT06273176 — intervention group
Intervention type: PROCEDURE
Intervention: Asleep mapping under general anesthesia
Description: During asleep mapping under general anesthesia, the surgeon uses electro(sub)cortical mapping with evoked potentials (MEPs, SSEPs or continuous dynamic mapping) to prevent damage to eloquent areas.
Study NCT06273176 — intervention group
Intervention type: PROCEDURE
Intervention: Resection under general anesthesia without mapping
Description: During resection under general anesthesia without mapping, the surgeon does not use any intraoperative stimulation mapping techniques to identify eloquent areas.
Study NCT05720325 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dupilumab
Description: Dupixent is an interleukin-4 receptor alpha antagonist
Study NCT05720325 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dupilumab
Description: Dupixent is an interleukin-4 receptor alpha antagonist
Study NCT05720325 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: House Dust Mites (HDM)
Description: House Dust Mites used to challenge subjects using an aeroallergen challenge chamber
Study NCT05720325 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: House Dust Mites (HDM)
Description: House Dust Mites used to challenge subjects using an aeroallergen challenge chamber
Study NCT05720325 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: House Dust Mites (HDM)
Description: House Dust Mites used to challenge subjects using an aeroallergen challenge chamber
Study NCT05720325 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Inert placebo administered to placebo arms of study.
Study NCT05374811 — intervention group
Intervention type: OTHER
Intervention: Neuropathic Pain
Description: Neuropathic pain degrees of the patients will be evaluated with the Douleur Neuropathic-4 (DN4) questionnaire.
Study NCT05476562 — intervention group
Intervention type: OTHER
Intervention: Tyrosine Kinase Inhibitors (TKIs)
Description: The study included patients with CML who were previously treated with TKIs, who are relapsed/refractory to/intolerant of TKIs on third or later lines of therapy in the US.
Study NCT05322187 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PD-1 inhibitor
Description: Sequential PD-1/PD-L1 Inhibitor and LENvatinib treatment after chemotherapy resistance
Study NCT06210529 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: a high-intensity focused ultrasound tumor treatment system (Super Knife)
Description: All participants will be randomly divided into groups A and B. Participants in group A will receive a high-intensity focused ultrasound tumor treatment (Super Knife) once, and participants in group B will receive treatment twice (4 weeks, one cycle).. Breast cancer surgery was performed at 3 months ± 1 week after the Super Knife treatment.
Study NCT02341339 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laparoscopic Surgery (Biopsies of fallopian tube lumen) using a laparoscopic brush/biopsy device
Study NCT05627635 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo a PET scan
Study NCT05627635 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: X-Ray Imaging
Description: Undergo an x-ray
Study NCT05467748 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tulmimetostat
Description: combination of oral tazemetostat and intravenous pembrolizumab treatment for patients with advanced non-small cell lung cancer
Study NCT06141707 — intervention group
Intervention type: OTHER
Intervention: Arabic pediatric sleep questionnaire
Description: Pediatric Sleep Questionnaire (PSQ) developed and validated by chervil et al. (2000) is a 22 item questionnaire which had been shown to have a sensitivity of 81% and specificity of 87% for SRBD.These scales for childhood SRBDs, snoring, sleepiness, and behavior are valid and reliable instruments that can be used to identify SRBDs or associated symptom-constructs in clinical research when polysomnography is not feasible.
Study NCT04958889 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: (observational study)
Study NCT04932239 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: first aid education
Description: To teach commercial motorcyclists first aid for post-crash while waiting for medical team to reach the scene
Study NCT04932239 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: first aid education
Description: To teach commercial motorcyclists first aid for post-crash while waiting for medical team to reach the scene
Study NCT05771766 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Postural Drainge and aerobic training
Description: This will be a randomized controlled trial Patients will be divided into two groups randomly. Both groups will receive postural drainage as baseline treatment thrice a week for two weeks. The intervention group will undergo additional Aerobic Training thrice a week for two weeks as well along with postural drainage. Aerobic training will include 5-step stair-climbing and 10 step walk during each session.
Study NCT05771766 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Postural Drainage
Description: Postural Drainage
Study NCT06472115 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Supportive Parenting for Anxious Childhood Emotions (SPACE) for insistence on sameness (IS)
Description: This study will examine the potential effectiveness of a virtually delivered parent-mediated intervention for insistence on sameness behaviors in autism. This includes a 16 week protocol where caregivers meet weekly for one hour with a study therapist.
Study NCT06188026 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NNC0194-0499
Description: Once a week for 5 weeks as an injection in dose of 30 mg. The injection will be given under the skin